Black AM - Search Results

1

The reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: can a case be made for a 3-month therapeutic trial?

Black AM, Day AG, Morales A. Black AM, et al. BJU Int. 2004 Nov;94(7):1066-70. doi: 10.1111/j.1464-410X.2004.05105.x. BJU Int. 2004. PMID: 15541129

2

Clinical practice experience with testosterone treatment in men with testosterone deficiency syndrome.

McLaren D, Siemens DR, Izard J, Black A, Morales A. McLaren D, et al. BJU Int. 2008 Nov;102(9):1142-6. doi: 10.1111/j.1464-410X.2008.07811.x. Epub 2008 Jun 6. BJU Int. 2008. PMID: 18540933

3

Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction and androgen deficiency.

Morales A, Black A, Emerson L, Barkin J, Kuzmarov I, Day A. Morales A, et al. Aging Male. 2009 Dec;12(4):104-12. doi: 10.3109/13685530903294388. Aging Male. 2009. PMID: 19883295 Free article. Clinical Trial.

4

Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations.

Morales A, Black AM, Emerson LE. Morales A, et al. Among authors: black am. BJU Int. 2009 Jan;103(1):62-4. doi: 10.1111/j.1464-410X.2008.07882.x. Epub 2008 Jul 29. BJU Int. 2009. PMID: 18671790

5

A novel approach to premature ejaculation: extracorporeal functional magnetic stimulation.

Morales A, Black A, Clark-Pereira J, Emerson L. Morales A, et al. Can J Urol. 2009 Feb;16(1):4458-62. Can J Urol. 2009. PMID: 19222883

6

The significance of biological variation in the diagnosis of testosterone deficiency, and consideration of the relevance of total, free and bioavailable testosterone determinations.

Collier CP, Morales A, Clark A, Lam M, Wynne-Edwards K, Black A. Collier CP, et al. J Urol. 2010 Jun;183(6):2294-9. doi: 10.1016/j.juro.2010.02.011. Epub 2010 Apr 18. J Urol. 2010. PMID: 20400148

7

Adding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry.

Morales A, Spevack M, Emerson L, Kuzmarov I, Casey R, Black A, Tremblay R. Morales A, et al. Aging Male. 2007 Jun;10(2):57-65. doi: 10.1080/13685530701342686. Aging Male. 2007. PMID: 17558969 Free article.

8

Testosterone deficiency syndrome and prostate cancer: illustrative annotations for a debate.

Morales A, Black A. Morales A, et al. Can Urol Assoc J. 2008 Feb;2(1):52-4. doi: 10.5489/cuaj.528. Can Urol Assoc J. 2008. PMID: 18542732 Free PMC article. No abstract available.

9

Serum follicle-stimulating hormone levels predict time to development of castration-resistant prostate cancer.

Hoare D, Skinner TA, Black A, Robert Siemens D. Hoare D, et al. Can Urol Assoc J. 2015 Mar-Apr;9(3-4):122-7. doi: 10.5489/cuaj.2545. Can Urol Assoc J. 2015. PMID: 26085869 Free PMC article.

10

Effects of androgen-deprivation therapy on hypercoagulability in prostate cancer patients: A prospective, longitudinal study.

Kaur H, Siemens DR, Black A, Robb S, Barr S, Graham CH, Othman M. Kaur H, et al. Can Urol Assoc J. 2017 Jan-Feb;11(1-2):33-38. doi: 10.5489/cuaj.3936. Can Urol Assoc J. 2017. PMID: 28443142 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters